'Pivotal trials' presentation slideshows

Targeting HER family receptors in breast cancer

885 views • 52 slides

The Methods for Translational Mitral/Tricuspid Valve Development

The Methods for Translational Mitral/Tricuspid Valve Development. Michael Mack, MD Baylor Scott & White Health Dallas, TX. Conflict of Interest Disclosure. Abbott Vascular- Co PI COAPT Trial Medtronic- Study Chair-APOLLO Trial Edwards Lifesciences- Co-PI PARTNER 3 Trial.

493 views • 48 slides

Ranibizumab and bevacizumab for neovascular armd * The CATT research group*

Ranibizumab and bevacizumab for neovascular armd * The CATT research group*. Juan G. Santiago, MD Valley Retina Institute, P.A. May 6, 2011. Background. In 2005, clinical trials have established the efficacy of ranibizumab ( Lucentis ) for the treatment of neovascular AMD.

602 views • 42 slides

272 views • 15 slides

OVERVIEW

ADVAIR and FLOVENT DISKUS Supplements for the COPD indication: SUMMARY and QUESTIONS Mary Purucker, MD, PhD Medical Team Leader Division of Pulmonary and Allergy Drug Products CDER, USFDA. OVERVIEW. Efficacy Summary Safety Summary Corticosteroid-related Issues Pivotal Trials

259 views • 13 slides

Could an EOP2A Meeting Shorten Drug Development Time?

Could an EOP2A Meeting Shorten Drug Development Time?. Joga Gobburu Team Leader, Pharmacometrics, OCPB/CDER/FDA Based on the work jointly performed with Drs. Nguyen and Marroum. Background. Drug with symptomatic benefit Proposed dosing - QD Sustained effect desired

335 views • 13 slides